Bronchoscopy with BAL was performed, with lavage samples notable for their opaque, milky character. BAL fluid cytology demonstrated reactive bronchial cells and proteinaceous debris, but did not ...

Pulmonary alveolar proteinosis is a rare disorder in which lipoproteinaceous material accumulates within alveoli. 1 The clinical course of the disease is variable, ranging from respiratory failure ...

Schoch OD, Schanz U, Koller M, et al. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF. Thorax 2002;57:277-280. Crossref ...

The Effects of Molgramostim on Respiratory Health-related Quality of Life and Patient-reported Outcomes in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Molgramostim showed ...

Below are summaries of the posters presented: Poster Board 701: “Healthcare Burden of Pulmonary Alveolar Proteinosis” presented by E. Lee, M.D., Ph.D.; sponsored by Savara Inc. Poster Board ...

"We can observe this phenomenon in patients with pulmonary alveolar proteinosis (PAP). They suffer from shortness of breath, an impaired respiratory function and an increased risk of lung infections.

Poster Board 701: "Healthcare Burden of Pulmonary Alveolar Proteinosis" presented by E. Lee, M.D., Ph.D.; sponsored by Savara Inc. Presented data from a retrospective cohort analysis using a ...

Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare lung disease that belongs to a family of distinct rare lung diseases collectively known as pulmonary alveolar proteinosis (PAP).